R. Erik Holmlin

CIK: 0001579988

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)4 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BNGO

Bionano Genomics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

BNGO
Bionano Genomics, Inc.
Feb 17, 2026
Tax Payment(F)
Direct
51 shares at avg. $1.10$56.1
BNGO
Bionano Genomics, Inc.
Feb 2, 2026
Award(A)
Stock Option (Right to Buy)
Direct
69.5K shares-
BNGO
Bionano Genomics, Inc.
Jun 3, 2025
Tax Payment(F)
Direct
75 shares at avg. $3.69$276.75
BNGO
Bionano Genomics, Inc.
Mar 14, 2025
Tax Payment(F)
Direct
198 shares at avg. $3.47$687.06
BNGO
Bionano Genomics, Inc.
Mar 14, 2025
Award(A)
Stock Option (Right to Buy)
Direct
17.4K shares-
BNGO
Bionano Genomics, Inc.
Feb 15, 2025
Tax Payment(F)
Direct
51 shares at avg. $5.73$292.23

		Type	Shares	Price		Ownership
Feb 17, 2026	BNGO Bionano Genomics, Inc.	Tax Payment(F)	51	$1.10	$56	Direct
Feb 2, 2026	BNGO Bionano Genomics, Inc.	Award(A) Stock Option (Right to Buy)	69,484	-	-	Direct
Jun 3, 2025	BNGO Bionano Genomics, Inc.	Tax Payment(F)	75	$3.69	$277	Direct
Mar 14, 2025	BNGO Bionano Genomics, Inc.	Tax Payment(F)	198	$3.47	$687	Direct
Mar 14, 2025	BNGO Bionano Genomics, Inc.	Award(A) Stock Option (Right to Buy)	17,449	-	-	Direct
Feb 15, 2025	BNGO Bionano Genomics, Inc.	Tax Payment(F)	51	$5.73	$292	Direct

1-6 of 6 transactions

About Holmlin R. Erik

Holmlin R. Erik (SEC CIK 0001579988) files insider reports with the SEC as PRESIDENT AND CEO of Bionano Genomics, Inc. (BNGO).

Signal8 holds 5 ownership filings by Holmlin R. Erik, all Form 4s, filed between Feb 19, 2025 and Feb 18, 2026. Those filings report 6 transactions, from Feb 15, 2025 to Feb 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Holmlin R. Erik's filings is in SAN DIEGO, CA.

Recent filings by Holmlin R. Erik

Feb 17, 2026: Tax withholding of BNGO shares (Form 4, code F).
Feb 2, 2026: Grant or award of BNGO derivative securities (Form 4, code A).
Jun 3, 2025: Tax withholding of BNGO shares (Form 4, code F).
Mar 14, 2025: Tax withholding of BNGO shares (Form 4, code F).
Mar 14, 2025: Grant or award of BNGO derivative securities (Form 4, code A).

Other insiders filing for Bionano Genomics, Inc. (BNGO)

Luderer Albert, Interim Chief Executive
Adamchak Mark, Principal Accounting Officer
Dixon Jonathan V., General Counsel
OLDAKOWSKI MARK, Chief Operating Officer
Hastie Alex Reid, Chief Scientific Officer
Chaubey Alka, CHIEF MEDICAL OFFICER

How to read Form 4 transaction codes